Cardio Diagnostics Ownership 2024 | Who Owns Cardio Diagnostics Now?

Overview RevenueFinancials Chart

Institutional Ownership

10.85%

Insider Ownership

13.03%

Retail Ownership

76.12%

Institutional Holders

11.00

Cardio Diagnostics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
LINDEN ADVISORS LP	2.78%	0.00%	85,713	-	-	335,138,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	2.41%	-	74,284	74,284	100.00%	290,450,000	Mar 31, 2023
VANGUARD GROUP INC	2.07%	-	64,022	64,022	100.00%	250,326,000	Mar 31, 2023
STATE STREET CORP	1.35%	-	41,700	41,700	100.00%	163,047,000	Mar 31, 2023
PNC FINANCIAL SERVICES GROUP, INC.	1.31%	0.00%	40,500	40,500	100.00%	158,355,000	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.49%	-	15,000	15,000	100.00%	58,650,000	Mar 31, 2023
CALDWELL SUTTER CAPITAL, INC.	0.26%	0.02%	8,101	-	-	31,675,000	Mar 31, 2023
UBS GROUP AG	0.09%	-	2,681	1,297	93.71%	10,483,000	Mar 31, 2023
WOLVERINE ASSET MANAGEMENT LLC	0.05%	0.00%	1,538	1,538	100.00%	6,013,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.04%	0.00%	1,304	1,304	100.00%	5,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	41	-	-	160,000	Mar 31, 2023
POLAR ASSET MANAGEMENT PARTNERS INC.	-	-	-	-25,698	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-3	-100.00%	-	Mar 31, 2023
YAKIRA CAPITAL MANAGEMENT, INC.	-	-	-	-20,757	-100.00%	-	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	-	-	-	-23,646	-100.00%	-	Mar 31, 2023
D. E. SHAW & CO., INC.	-	-	-	-20,077	-100.00%	-	Mar 31, 2023
BOOTHBAY FUND MANAGEMENT, LLC	-	-	-	-13,572	-100.00%	-	Mar 31, 2023
CONTEXT CAPITAL MANAGEMENT, LLC	-	-	-	-16,278	-100.00%	-	Mar 31, 2023
ATW SPAC MANAGEMENT LLC	-	-	-	-13,572	-100.00%	-	Mar 31, 2023

Cardio Diagnostics's largest institutional shareholder is LINDEN ADVISORS LP, holding 2.78% of the company's total share outstanding, currently valued at $335.14M. The top 10 institutional shareholders own together 10.84% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CALDWELL SUTTER CAPITAL, INC.	0.26%	0.02%	8,101	-	-	31,675,000	Mar 31, 2023
LINDEN ADVISORS LP	2.78%	0.00%	85,713	-	-	335,138,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.04%	0.00%	1,304	1,304	100.00%	5,000	Mar 31, 2023
PNC FINANCIAL SERVICES GROUP, INC.	1.31%	0.00%	40,500	40,500	100.00%	158,355,000	Mar 31, 2023
WOLVERINE ASSET MANAGEMENT LLC	0.05%	0.00%	1,538	1,538	100.00%	6,013,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	2.41%	-	74,284	74,284	100.00%	290,450,000	Mar 31, 2023
STATE STREET CORP	1.35%	-	41,700	41,700	100.00%	163,047,000	Mar 31, 2023
VANGUARD GROUP INC	2.07%	-	64,022	64,022	100.00%	250,326,000	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.49%	-	15,000	15,000	100.00%	58,650,000	Mar 31, 2023
UBS GROUP AG	0.09%	-	2,681	1,297	93.71%	10,483,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	41	-	-	160,000	Mar 31, 2023
POLAR ASSET MANAGEMENT PARTNERS INC.	-	-	-	-25,698	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-3	-100.00%	-	Mar 31, 2023
YAKIRA CAPITAL MANAGEMENT, INC.	-	-	-	-20,757	-100.00%	-	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	-	-	-	-23,646	-100.00%	-	Mar 31, 2023
D. E. SHAW & CO., INC.	-	-	-	-20,077	-100.00%	-	Mar 31, 2023
BOOTHBAY FUND MANAGEMENT, LLC	-	-	-	-13,572	-100.00%	-	Mar 31, 2023
CONTEXT CAPITAL MANAGEMENT, LLC	-	-	-	-16,278	-100.00%	-	Mar 31, 2023
ATW SPAC MANAGEMENT LLC	-	-	-	-13,572	-100.00%	-	Mar 31, 2023

The largest Cardio Diagnostics shareholder by % of total assets is CALDWELL SUTTER CAPITAL, INC.. The company owns 8.10K shares of Cardio Diagnostics (CDIO), representing 0.02% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
GEODE CAPITAL MANAGEMENT, LLC	2.41%	-	74,284	74,284	100.00%	290,450,000	Mar 31, 2023
VANGUARD GROUP INC	2.07%	-	64,022	64,022	100.00%	250,326,000	Mar 31, 2023
STATE STREET CORP	1.35%	-	41,700	41,700	100.00%	163,047,000	Mar 31, 2023
PNC FINANCIAL SERVICES GROUP, INC.	1.31%	0.00%	40,500	40,500	100.00%	158,355,000	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.49%	-	15,000	15,000	100.00%	58,650,000	Mar 31, 2023
WOLVERINE ASSET MANAGEMENT LLC	0.05%	0.00%	1,538	1,538	100.00%	6,013,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.04%	0.00%	1,304	1,304	100.00%	5,000	Mar 31, 2023
UBS GROUP AG	0.09%	-	2,681	1,297	93.71%	10,483,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	41	-	-	160,000	Mar 31, 2023
LINDEN ADVISORS LP	2.78%	0.00%	85,713	-	-	335,138,000	Mar 31, 2023
CALDWELL SUTTER CAPITAL, INC.	0.26%	0.02%	8,101	-	-	31,675,000	Mar 31, 2023
MORGAN STANLEY	-	-	-	-3	-100.00%	-	Mar 31, 2023
ATW SPAC MANAGEMENT LLC	-	-	-	-13,572	-100.00%	-	Mar 31, 2023
BOOTHBAY FUND MANAGEMENT, LLC	-	-	-	-13,572	-100.00%	-	Mar 31, 2023
CONTEXT CAPITAL MANAGEMENT, LLC	-	-	-	-16,278	-100.00%	-	Mar 31, 2023
D. E. SHAW & CO., INC.	-	-	-	-20,077	-100.00%	-	Mar 31, 2023
YAKIRA CAPITAL MANAGEMENT, INC.	-	-	-	-20,757	-100.00%	-	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	-	-	-	-23,646	-100.00%	-	Mar 31, 2023
POLAR ASSET MANAGEMENT PARTNERS INC.	-	-	-	-25,698	-100.00%	-	Mar 31, 2023

As of Mar 31 2023, Cardio Diagnostics's largest institutional buyer is GEODE CAPITAL MANAGEMENT, LLC. The company purchased 74.28K stocks of CDIO, valued at $290.45M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
POLAR ASSET MANAGEMENT PARTNERS INC.	-	-	-	-25,698	-100.00%	-	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	-	-	-	-23,646	-100.00%	-	Mar 31, 2023
YAKIRA CAPITAL MANAGEMENT, INC.	-	-	-	-20,757	-100.00%	-	Mar 31, 2023
D. E. SHAW & CO., INC.	-	-	-	-20,077	-100.00%	-	Mar 31, 2023
CONTEXT CAPITAL MANAGEMENT, LLC	-	-	-	-16,278	-100.00%	-	Mar 31, 2023
BOOTHBAY FUND MANAGEMENT, LLC	-	-	-	-13,572	-100.00%	-	Mar 31, 2023
ATW SPAC MANAGEMENT LLC	-	-	-	-13,572	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-3	-100.00%	-	Mar 31, 2023
CALDWELL SUTTER CAPITAL, INC.	0.26%	0.02%	8,101	-	-	31,675,000	Mar 31, 2023
LINDEN ADVISORS LP	2.78%	0.00%	85,713	-	-	335,138,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	41	-	-	160,000	Mar 31, 2023
UBS GROUP AG	0.09%	-	2,681	1,297	93.71%	10,483,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.04%	0.00%	1,304	1,304	100.00%	5,000	Mar 31, 2023
WOLVERINE ASSET MANAGEMENT LLC	0.05%	0.00%	1,538	1,538	100.00%	6,013,000	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.49%	-	15,000	15,000	100.00%	58,650,000	Mar 31, 2023
PNC FINANCIAL SERVICES GROUP, INC.	1.31%	0.00%	40,500	40,500	100.00%	158,355,000	Mar 31, 2023
STATE STREET CORP	1.35%	-	41,700	41,700	100.00%	163,047,000	Mar 31, 2023
VANGUARD GROUP INC	2.07%	-	64,022	64,022	100.00%	250,326,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	2.41%	-	74,284	74,284	100.00%	290,450,000	Mar 31, 2023

As of Mar 31 2023, Cardio Diagnostics's biggest institutional seller is POLAR ASSET MANAGEMENT PARTNERS INC.. The company sold -25.70K shares of CDIO, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
GEODE CAPITAL MANAGEMENT, LLC	2.41%	-	74,284	74,284	100.00%	290,450,000	Mar 31, 2023
VANGUARD GROUP INC	2.07%	-	64,022	64,022	100.00%	250,326,000	Mar 31, 2023
STATE STREET CORP	1.35%	-	41,700	41,700	100.00%	163,047,000	Mar 31, 2023
PNC FINANCIAL SERVICES GROUP, INC.	1.31%	0.00%	40,500	40,500	100.00%	158,355,000	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.49%	-	15,000	15,000	100.00%	58,650,000	Mar 31, 2023
WOLVERINE ASSET MANAGEMENT LLC	0.05%	0.00%	1,538	1,538	100.00%	6,013,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.04%	0.00%	1,304	1,304	100.00%	5,000	Mar 31, 2023

Cardio Diagnostics's largest new institutional shareholder by number of shares is GEODE CAPITAL MANAGEMENT, LLC, purchased 74.28K shares, valued at $290.45M, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
POLAR ASSET MANAGEMENT PARTNERS INC.	-	-	-	-25,698	-100.00%	-	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	-	-	-	-23,646	-100.00%	-	Mar 31, 2023
YAKIRA CAPITAL MANAGEMENT, INC.	-	-	-	-20,757	-100.00%	-	Mar 31, 2023
D. E. SHAW & CO., INC.	-	-	-	-20,077	-100.00%	-	Mar 31, 2023
CONTEXT CAPITAL MANAGEMENT, LLC	-	-	-	-16,278	-100.00%	-	Mar 31, 2023
BOOTHBAY FUND MANAGEMENT, LLC	-	-	-	-13,572	-100.00%	-	Mar 31, 2023
ATW SPAC MANAGEMENT LLC	-	-	-	-13,572	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-3	-100.00%	-	Mar 31, 2023

Cardio Diagnostics's largest sold out institutional shareholder by shares sold is POLAR ASSET MANAGEMENT PARTNERS INC., sold -25.70K shares, valued at -, as of undefined.

Cardio Diagnostics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
RIVERNORTH OPPORTUNITIES FUND, INC.	0.00%	4,456	-	-	Jan 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	145,125	71,879	98.13%	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	232,139	-232,139	-50.00%	Mar 31, 2024
FIRST TRUST ALTERNATIVE OPPORTUNITIES FUND	0.00%	-	-	-	Dec 31, 2023

Cardio Diagnostics's largest mutual fund holder by % of total assets is "RIVERNORTH OPPORTUNITIES FUND, INC.", owning 4.46K shares, compromising 0.00% of its total assets.

Cardio Diagnostics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 23	11	-8.33%
31 Dec, 22	12	-

As of 31 Mar 23, 11 institutions are holding Cardio Diagnostics's shares, representing a decrease of -8.33% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 23	334,884	46.34%
31 Dec, 22	228,842	-

Cardio Diagnostics (CDIO) has 334.88K shares outstanding as of 31 Mar 23, up 46.34% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 23	10.85%	-44.87%
31 Dec, 22	19.67%	-

As of 31 Mar 23, Cardio Diagnostics is held by 10.85% institutional shareholders, representing a -44.87% negative growth compared to 31 Dec 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 23	1	-
31 Dec, 22	-	-

1 institutional shareholders have increased their position in CDIO stock as of 31 Mar 23 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 23	-	-
31 Dec, 22	-	-

- institutional shareholders have reduced their position in CDIO stock as of 31 Mar 23 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 23	11	-8.33%	334,884	46.34%	10.85%	-44.87%	1	-	-	-
31 Dec, 22	12	-	228,842	-	19.67%	-	-	-	-	-

Cardio Diagnostics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Apr 08, 2024	Levy Oded	director	-	M-Exempt	Sell	-	-	-	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 02, 2024	Levy Oded	director	-	A-Award	Buy	7,575	$0.55	$4.17K	7,575
Jul 02, 2024	Lau Stanley K.	director	-	A-Award	Buy	7,575	$0.55	$4.17K	7,575
Jul 02, 2024	Intrater James	director	-	A-Award	Buy	7,575	$0.55	$4.17K	7,575
Jul 02, 2024	Burton Paul Frederick	director	-	A-Award	Buy	7,575	$0.55	$4.17K	7,575
Apr 08, 2024	Burton Paul Frederick	director	-	M-Exempt	Buy	8,803	$1.42	$12.50K	8,803
Apr 08, 2024	Burton Paul Frederick	director	-	M-Exempt	Buy	-	-	-	-
Apr 08, 2024	Lau Stanley K.	director	-	M-Exempt	Buy	8,803	$1.42	$12.50K	100,325
Apr 08, 2024	Lau Stanley K.	director	-	M-Exempt	Buy	-	-	-	-
Apr 08, 2024	Intrater James	director	-	M-Exempt	Buy	8,803	$1.42	$12.50K	71,596
Apr 08, 2024	Intrater James	director	-	M-Exempt	Buy	-	-	-	-
Apr 08, 2024	Levy Oded	director	-	M-Exempt	Buy	8,803	$1.42	$12.50K	71,596
Apr 08, 2024	Levy Oded	director	-	M-Exempt	Sell	-	-	-	-
Feb 21, 2024	Lau Stanley K.	director	-	A-Award	Buy	-	-	-	-
Feb 21, 2024	Intrater James	director	-	A-Award	Buy	-	-	-	-
Feb 21, 2024	Burton Paul Frederick	director	-	A-Award	Buy	-	-	-	-
Feb 21, 2024	Levy Oded	director	-	A-Award	Buy	-	-	-	-
Feb 21, 2024	Luqman Elisa V	officer	Chief Financial Officer	A-Award	Buy	35,719	$2.11	$75.37K	264,832
Feb 21, 2024	Abdullahi Khullani	officer	VP of Revenue and Strategy	A-Award	Buy	238,128	$2.11	$502.45K	304,128
Feb 21, 2024	Philibert Robert	director, officer	Chief Medical Officer	A-Award	Buy	142,876	$2.11	$301.47K	805,465
Feb 21, 2024	Hosseinion Warren	director	-	A-Award	Buy	35,719	$2.11	$75.37K	502,195

The last insider sell of Cardio Diagnostics's stock was made by Levy Oded on Apr 08 2024, selling - shares at - per share (valued at -).

Cardio Diagnostics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	4	-	-
Q1 2024	20	2	1000.00%
Q4 2023	7	5	140.00%
Q3 2023	22	4	550.00%
Q2 2023	23	-	-
Q4 2022	-	9	-
Q4 2021	1	5	20.00%

4 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Cardio Diagnostics's insiders, as of Q2 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	-	-	-
Q1 2024	-	-	-
Q4 2023	1	-	-
Q3 2023	9	-	-
Q2 2023	-	-	-
Q4 2022	-	-	-
Q4 2021	-	-	-

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Cardio Diagnostics's stocks.

Cardio Diagnostics Peer Ownership

Ticker	Company
ZVSA	ZyVersa Therapeutics, Inc.
CNSP	CNS Pharmaceuticals, Inc.
VECT	VectivBio Holding AG
PHIO	Phio Pharmaceuticals Corp.
AVRO	AVROBIO, Inc.
EFTR	eFFECTOR Therapeutics, Inc.
IMMX	Immix Biopharma, Inc.
CYTO	Altamira Therapeutics Ltd.
SONN	Sonnet BioTherapeutics Holdings, Inc.
PYXS	Pyxis Oncology, Inc.
ZURA	Zura Bio Limited
ELEV	Elevation Oncology, Inc.
ATNF	180 Life Sciences Corp.

CDIO Ownership FAQ

Who Owns Cardio Diagnostics?

Cardio Diagnostics is owned by institutional shareholders (10.85%), insiders (13.03%), and public (76.12%). The largest institutional shareholder of Cardio Diagnostics is LINDEN ADVISORS LP (2.78% of total shares) and the top mutual fund owner is RIVERNORTH OPPORTUNITIES FUND, INC. (0.00% of total shares).

Who are the major institutional shareholders of Cardio Diagnostics?

Cardio Diagnostics's major institutional shareholders are LINDEN ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, STATE STREET CORP, and PNC FINANCIAL SERVICES GROUP, INC.. The top five shareholders own together 9.92% of the company's share outstanding.

How many Cardio Diagnostics shareholders are there?

As of Mar 2023, there are 11 institutional shareholders of Cardio Diagnostics.

What percentage of Cardio Diagnostics is owned by LINDEN ADVISORS LP?

LINDEN ADVISORS LP owns 85.71K shares of Cardio Diagnostics, representing 2.78% of the company's total shares outstanding, valued at $335.14M (as of Mar 2023).

What percentage of Cardio Diagnostics is owned by GEODE CAPITAL MANAGEMENT, LLC?

As of Mar 2023, GEODE CAPITAL MANAGEMENT, LLC holds 74.28K shares of Cardio Diagnostics (CDIO), compromising 2.41% of the company, valued at $290.45M.

What percentage of Cardio Diagnostics is owned by VANGUARD GROUP INC?

VANGUARD GROUP INC is the third largest holder of Cardio Diagnostics. The company owns 64.02K of the company's shares outstanding (worth $250.33M).